Skip to main content Accessibility Statement

Investors

At Tactile Medical, a fundamental value is to earn a fair profit and return value for our shareholders

--

Minimum 15 minutes delayed. Source: LSEG

Upcoming Events

More events are coming soon.

Recent News

  • June 3, 2025

    New Data Demonstrates Significant Clinical and Quality-of-Life Benefits of Flexitouch® Plus in Treating Lymphedema Among Head and Neck Cancer Survivors

    Abstract Presented at ASCO 2025 Annual Meeting Features Two-Month Data from the Largest Randomized Trial Ever Conducted Among Head and Neck Cancer Survivors MINNEAPOLIS , June 03, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical

    Read more

  • May 20, 2025

    Tactile Medical to Present at Upcoming Investor Conferences in June

    MINNEAPOLIS , May 20, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will be participating in two upcoming investor

    Read more

  • May 5, 2025

    Tactile Systems Technology, Inc. Reports First Quarter 2025 Financial Results

    MINNEAPOLIS , May 05, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the first quarter ended March 31, 2025 .

    Read more